EcoDrugPlus

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSCHAG00000013963
Gene Symbol: LOC105897267
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCHAG00000021860
Gene Symbol: DRD1
3 Cross references
188 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCHAG00000003774
Gene Symbol: DRD3
1 Cross references
208 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSCHAG00000019148
Gene Symbol: DRD4
3 Cross references
176 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSCHAG00000018437
Gene Symbol: DRD4A
1 Cross references
176 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCHAG00000009936
Gene Symbol: DRD5
3 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCHAG00000016944
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCHAG00000006825
Gene Symbol: EGLN1
3 Cross references
222 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCHAG00000018286
Gene Symbol: EGLN1
3 Cross references
221 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSCHAG00000012832
Gene Symbol: EGLN3
3 Cross references
202 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSCHAG00000013797
Gene Symbol: EPAS1
3 Cross references
213 Possible Orthologues:

Endothelin B Receptor-Like

Ensembl ID : ENSCHAG00000003519
Gene Symbol: LOC105891433
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).